代謝機能障害に関連するステアトス性肝疾患と2型糖尿病: 病理生理学,診断,および新興の治療戦略
Mithil Gowda Suresh1, Safia Mohamed2, Harinivaas S Geetha1
1Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01608, United States.
World journal of diabetes
|February 16, 2026
まとめ
代謝機能障害に関連したステアトス性肝疾患 (MASLD) は,2型糖尿病 (T2DM) で一般的であり,肝臓および心臓病のリスクを増大します. 新しい薬と診断法は,糖尿病患者のこの状態の管理に希望を与えます.
科学分野:
- ヘパトロジーと内分泌学
- メタボリック障害 メタボリック障害
- 心血管の健康についてです.
背景:
- 代謝機能障害に関連したステアトス性肝疾患 (MASLD) は,2型糖尿病 (T2DM) で非常に一般的です.
- MASLDは,T2DM患者の進行性肝疾患 (線維症,肝硬変,肝細胞癌) と心血管疾患による死亡率のリスクを大幅に高めます.
- 病原発生には,インスリン抵抗性,脂質不全症,ミトコンドリア機能障害,炎症,遺伝学が含まれています.
研究 の 目的:
- T2DMにおけるMASLDの疫学,病原性,診断,治療に関する現在の証拠をレビューする.
- 非侵襲的診断と新薬療法における進歩を強調する.
- この接近する流行病に対する精密医療と多学科ケアにおける将来の方向性について議論する.
主な方法:
- 既存の文献を合成したナラティブレビュー.
- 疫学データの分析,機械的洞察,診断ツール,治療戦略.
- 肝臓に有益な抗糖尿病薬を含む,現在および新興の薬剤療法の評価.
主要な成果:
- MASLDはT2DM患者の大半に影響し,重度の肝臓合併症や心血管疾患のリスクを高めます.
- 非侵襲的診断ツールは有望だが,糖尿病患者では限界がある.
- いくつかの抗糖尿病薬 (GLP-1 RAs,SGLT-2阻害剤,ピオグリタゾン) は,血糖制御を超えて肝臓に有意義な効果を示しています.
結論:
- MASLDはT2DMにおける重要な併発症であり,統合管理が必要である.
- 新興の薬剤療法と改善された診断は,T2DMにおけるMASLD治療を変革しています.
- 精密医療と多学科医療は,T2DMにおけるMASLDの増大する負担に対処するために不可欠です.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Carbohydrate Metabolism
14.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.4K
Pathophysiology of Diabetes
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
Chronic Pancreatitis II: Collaborative Care
388
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
388
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212


